<?xml version="1.0" encoding="UTF-8"?>
<p>However, pre-treatment with resolvin D1, a pro-resolution mediator and another agonist for FPR2, reduces the pro-inflammatory effects associated with TLR3 agonist (Poly I:C) treatment in human airway epithelial cells (
 <xref rid="B32" ref-type="bibr">Hsiao et al., 2014</xref>). Although Poly I:C is a viral mimetic and not an actual virus, it is possible that FPR2 activation by Resolvin D1, may be useful in attenuating the inflammatory effects of IAV infection, which happens to be the detrimental side effect of flu infection.
</p>
